{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-027585","form_type":"8-K","ticker":"ALKS","cik":"0001520262","company_name":"Alkermes plc.","filed_at":"2024-03-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.477770+00:00","generated_at":"2026-06-05T01:28:13.508391+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Alkermes appoints Nancy S. Lurker to Board of Directors, increasing size to 11","bullets":["Board expanded to 11 directors; Nancy S. Lurker elected effective March 5, 2024, term expiring at 2024 annual meeting.","Lurker brings decades of pharmaceutical/biotech leadership and commercial expertise; CEO highlights alignment with growth strategy.","She will receive standard new director equity grant and annual cash retainer; equity grants in April 2024 subject to re-election forfeiture.","Lurker not a party to any related-party transactions since Jan 1, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-027585","json":"https://secwatch.observer/filing/0000950170-24-027585.json","markdown":"https://secwatch.observer/filing/0000950170-24-027585.md","text":"https://secwatch.observer/filing/0000950170-24-027585.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1520262/000095017024027585/0000950170-24-027585-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1520262/000095017024027585/alks-20240305.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T01:28:13.508391+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a6d7023722","claim":"Nancy S. Lurker was elected as Director at Alkermes plc..","evidence_excerpt":"Effective March 5, 2024, the board of directors (the “Board”) of Alkermes plc (the “Company”) increased the size of the Board to eleven (11) directors and elected Nancy S. Lurker to the Board, with an initial term expiring at the Company’s 2024 annual general meeting of shareholders (the “2024 Annual Meeting”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1520262/000095017024027585/0000950170-24-027585-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}